| Literature DB >> 1369396 |
Abstract
Significant advances in the areas of identification of disease susceptibility genes and gene transfer technologies have fueled new initiatives in cellular engineering as a means for treating metabolic disease. This article utilizes new findings from such work as the blueprint for a discussion of the prospects for gene therapy in diabetes mellitus.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1369396 DOI： 10.1038/nbt1092-1112
Source DB: PubMed Journal: Biotechnology (N Y) ISSN： 0733-222X